Re-188 Enhances the Inhibitory Effect of Bevacizumab in Non-Small-Cell Lung Cancer

The malignant behaviors of solid tumors such as growth, infiltration and metastasis are mainly nourished by tumor neovascularization. Thus, anti-angiogenic therapy is key to controlling tumor progression. Bevacizumab, a humanized anti-vascular endothelial growth factor (VEGF) antibody, plus chemothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Jie, Xu, Xiaobo, Li, Xiao, Li, Yanli, Liu, Guobing, Tan, Hui, Shen, Hua, Shi, Hongcheng, Cheng, Dengfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6273882/
https://www.ncbi.nlm.nih.gov/pubmed/27706035
http://dx.doi.org/10.3390/molecules21101308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6273882/
https://www.ncbi.nlm.nih.gov/pubmed/27706035
http://dx.doi.org/10.3390/molecules21101308

Ejemplares similares